Novavax Inc. Stock
.jpg?locale=us "jomobb")
Novavax Inc. Stock
Novavax Inc. shows a slight decrease today, losing -€0.280 (-0.170%) compared to yesterday.
Our community is currently high on Novavax Inc. with 8 Buy predictions and 3 Sell predictions.
With a target price of €185.00 there is a slightly positive potential of 14.750% for Novavax Inc. compared to the current price of €161.22.
Our community identified positive and negative aspects for Novavax Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Novavax Inc. stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of Novavax Inc. in the next few years
Pros
4
Could be worthwhile Investment >10% per year
2
Very Future proof/growth oriented business model
2
Leading role in innovation
Cons
2
Significant cyclical dependencies
1
High risks for its business
Performance of Novavax Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novavax Inc. | -0.170% | 6.627% | 32.954% | 134.297% | 66.825% | 510.682% | 33.240% |
| Vanda Pharmaceuticals | -0.630% | -3.049% | 8.163% | 52.885% | 50.000% | - | - |
| Harrow Health Inc. | 12.260% | 26.087% | 8.075% | 91.630% | 88.312% | - | - |
| Corbus Pharmaceuticals Holdings Inc | 2.610% | -0.259% | 23.961% | -75.627% | 68.583% | - | - |
